Paul J. Emmerson

2.9k citations

34 papers · 1.7k indexed · 1 hit paper · h-index 21

Cellular and Molecular Neuroscience top 2%
- Neuropeptides and Animal Physiology 19
Endocrine and Autonomic Systems top 5%
- Regulation of Appetite and Obesity 8
Endocrinology, Diabetes and Metabolism top 5%
- Diabetes Treatment and Management 6
Physiology top 5%
- Nutrition and Health in Aging 4
Molecular Biology top 10%
- Receptor Mechanisms and Signaling 18
- Pharmacological Receptor Mechanisms and Effects 8
Nutrition and Dietetics
- Biochemical Analysis and Sensing Techniques 4
Rheumatology
- GDF15 and Related Biomarkers 4

Co-authors: Fedor Medzihradsky J H Woods Huda Akil Mary J. Clark Alfred Mansour Richard J. Miller Gregory A. Kinney Kyle W. Sloop
Cited by: Cellular and Molecular Neuroscience Endocrine and Autonomic Systems Endocrinology, Diabetes and Metabolism
Journals: Nature Communications (1 paper)Journal of Neuroscience (2 papers)PLoS ONE (2 papers)
Partner nations: United States United Kingdom Italy

In The Last Decade

Paul J. Emmerson

34 papers receiving 1.6k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Paul J. Emmerson

Since Specialization

Citations

This map shows the geographic impact of Paul J. Emmerson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul J. Emmerson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul J. Emmerson more than expected).

Fields of papers citing papers by Paul J. Emmerson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul J. Emmerson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul J. Emmerson. The network helps show where Paul J. Emmerson may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Paul J. Emmerson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Paul J. Emmerson Line = papers co-authored together Paul J. Emmerson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Brainstem BDNF neurons are downstream of GFRAL/GLP1R signalling Nature Communications ·Claire H. Feetham,Valeria Collabolletta,Amy A. Worth,Rosemary Shoop,Sam Groom,Court Harding,Mehdi Boutagouga Boudjadja,Tamer Coşkun,Paul J. Emmerson,Giuseppe D’Agostino,Simon M. Luckman	2024	5
2	Identification of AgRP cells in the murine hindbrain that drive feeding Molecular Metabolism ·Tomás P. Bachor,Eun‐Sang Hwang,Ernie Yulyaningsih,Kush Attal,F. Mifsud,Viana Pham,Eirini Vagena,Renzo Huarcaya,Martín Valdearcos,Christian Vaisse,Kevin W. Williams,Paul J. Emmerson,Allison Xu	2024	6
3	Discovery, development, and clinical proof of mechanism of LY3463251, a long-acting GDF15 receptor agonist Cell Metabolism ·Olivier Bénichou,Tamer Coşkun,Malgorzata D. Gonciarz,Parag Garhyan,Andrew C. Adams,Yu Du,James D. Dunbar,Jennifer A. Martin,Kieren J. Mather,Richard T. Pickard,Vincent L. Reynolds,Deborah A. Robins,Simbarashe P. Zvada,Paul J. Emmerson	2023	52
4	The hypothalamic RFamide, QRFP, increases feeding and locomotor activity: The role of Gpr103 and orexin receptors PLoS ONE ·Chris Cook,Nicolas Nunn,Amy A. Worth,David A. Bechtold,Todd M. Suter,Susan Gackeheimer,Lisa Foltz,Paul J. Emmerson,Michael A. Statnick,Simon M. Luckman	2022	8
5	Anorectic and aversive effects of GLP-1 receptor agonism are mediated by brainstem cholecystokinin neurons, and modulated by GIP receptor activation Molecular Metabolism ·Alessia Costa,Minrong Ai,Nicolas Nunn,Isabella Culotta,Jenna Hunter,Mehdi Boutagouga Boudjadja,Lourdes Valencia-Torres,Gabriella Aviello,David J. Hodson,Brandy M. Snider,Tamer Coşkun,Paul J. Emmerson,Simon M. Luckman,Giuseppe D’Agostino	2021	48
6	Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonistbreakdown → JCI Insight ·Francis S. Willard,Jonathan D. Douros,M Gabe,Aaron D. Showalter,David B. Wainscott,Todd M. Suter,Megan E. Capozzi,Wijnand J. C. van der Velden,Cynthia Stutsman,Guemalli R. Cardona,Shweta Urva,Paul J. Emmerson,Jens J. Holst,David A. D’Alessio,Matthew P. Coghlan,Mette M. Rosenkilde,Jonathan E. Campbell,Kyle W. Sloop	2020	314
7	The cytokine GDF15 signals through a population of brainstem cholecystokinin neurons to mediate anorectic signalling eLife ·Amy A. Worth,Rosemary Shoop,Katie Tye,Claire H. Feetham,Giuseppe D’Agostino,Garron T. Dodd,Frank Reimann,Fiona M. Gribble,Emily Beebe,James D. Dunbar,Jesline Alexander-Chacko,Dana K. Sindelar,Tamer Coşkun,Paul J. Emmerson,Simon M. Luckman	2020	63
8	Long-Acting and Selective Oxytocin Peptide Analogs Show Antidiabetic and Antiobesity Effects in Male Mice Journal of the Endocrine Society ·Brandy M. Snider,Andrea Geiser,Xiaopeng Yu,Emily Beebe,Jill A. Willency,Keyun Qing,Lili Guo,Jian‐Liang Lu,Xiaojun Wang,Qian Yang,Alexander M. Efanov,Andrew C. Adams,Tamer Coşkun,Paul J. Emmerson,Jorge Alsina‐Fernandez,Minrong Ai	2019	29
9	GDF15 and Growth Control Frontiers in Physiology ·Paul J. Emmerson,Kevin L. Duffin,Sudhakar Chintharlapalli,Xinle Wu	2018	134
10	Correlation of disease severity with body weight and high fat diet in the FATZO/Pco mouse PLoS ONE ·Brian A. Droz,Bria L. Sneed,Charles V. Jackson,Karen Zimmerman,M. Dodson Michael,Paul J. Emmerson,Tamer Coşkun,Richard G. Peterson	2017	14
11	Structure–activity relationship studies of carboxamido-biaryl ethers as opioid receptor antagonists (OpRAs). Part 1 Bioorganic & Medicinal Chemistry Letters ·Kumiko Takeuchi,William G. Holloway,Jamie H. McKinzie,Todd M. Suter,Michael A. Statnick,Peggy L. Surface,Paul J. Emmerson,Elizabeth Thomas,Miles G. Siegel,James E. Matt,Chad N. Wolfe,Charles H. Mitch	2007	9
12	Structure activity relationship studies of carboxamido-biaryl ethers as opioid receptor antagonists (OpRAs). Part 2 Bioorganic & Medicinal Chemistry Letters ·Kumiko Takeuchi,William G. Holloway,Charles H. Mitch,Steven J. Quimby,Jamie H. McKinzie,Todd M. Suter,Michael A. Statnick,Peggy L. Surface,Paul J. Emmerson,Elizabeth Thomas,Miles G. Siegel	2007	10
13	Potent and selective MC-4 receptor agonists based on a novel disulfide scaffold Bioorganic & Medicinal Chemistry Letters ·Liang Yan,David B. Flora,Patrick J. B. Edwards,David L. Smiley,Paul J. Emmerson,Hansen M. Hsiung,Robert A. Gadski,JeAnne Hertel,Mark L. Heiman,Saba Husain,Thomas P. O’Brien,Steven D. Kahl,Lianshan Zhang,Richard D. DiMarchi,John P. Mayer	2005	8
14	SAR and biological evaluation of novel trans-3,4-dimethyl-4-arylpiperidine derivatives as opioid antagonists Bioorganic & Medicinal Chemistry Letters ·Nuria Cirauqui,Mark J. Benvenga,Paul J. Emmerson,Ryan Favors,Michael Mangold,Jamie H. McKinzie,Nita Patel,Steven Peters,Steven J. Quimby,Harlan E. Shannon,Miles G. Siegel,Michael A. Statnick,Elizabeth Thomas,Joseph M. Woodland,Peggy L. Surface,Charles H. Mitch	2005	11
15	Development of Displacement Binding and GTPγS Scintillation Proximity Assays for the Identification of Antagonists of the μ-Opioid Receptor Assay and Drug Development Technologies ·George H. Rodgers,Cassandra Hubert,Jamie H. McKinzie,Todd M. Suter,Michael A. Statnick,Paul J. Emmerson,Louis F. Stancato	2003	9
16	Pre‐ and postsynaptic actions of opioid and orphan opioid agonists in the rat arcuate nucleus and ventromedial hypothalamus in vitro The Journal of Physiology ·Paul J. Emmerson,Richard J. Miller	1999	66
17	Synthesis and Characterization of 4,4-Difluoro-4-bora-3a,4a-Diaza-s-Indacene (BODIPY)-Labeled Fluorescent Ligands for the Mu Opioid Receptor Biochemical Pharmacology ·Paul J. Emmerson,Sydney Archer,Wageeh S. El‐Hamouly,Alfred Mansour,Huda Akil,Fedor Medzihradsky	1997	32
18	Regulation of Neurotransmission in the Arcuate Nucleus of the Rat by Different Neuropeptide Y Receptors Journal of Neuroscience ·Hyewhon Rhim,Gregory A. Kinney,Paul J. Emmerson,Richard J. Miller	1997	46
19	Characterization of opioid agonist efficacy in a C6 glioma cell line expressing the mu opioid receptor. Journal of Pharmacology and Experimental Therapeutics ·Paul J. Emmerson,Mary J. Clark,Alfred Mansour,Huda Akil,J H Woods,Fedor Medzihradsky	1996	167
20	Lipophilicity of opioids determined by a novel micromethod Journal of Pharmacological and Toxicological Methods ·Fedor Medzihradsky,Paul J. Emmerson,Carol Mousigian	1992	10

About Paul J. Emmerson

Paul J. Emmerson is a scholar working on Endocrine and Autonomic Systems, Cellular and Molecular Neuroscience and Endocrinology, Diabetes and Metabolism, having authored 34 papers that have together received 1.7k indexed citations. Recurring topics across this work include Neuropeptides and Animal Physiology (19 papers), Receptor Mechanisms and Signaling (18 papers), Pharmacological Receptor Mechanisms and Effects (8 papers), Regulation of Appetite and Obesity (8 papers), Diabetes Treatment and Management (6 papers), Biochemical Analysis and Sensing Techniques (4 papers), Nutrition and Health in Aging (4 papers) and GDF15 and Related Biomarkers (4 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (794 citations), Endocrine and Autonomic Systems (214 citations) and Endocrinology, Diabetes and Metabolism (373 citations). Paul J. Emmerson has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Fedor Medzihradsky, J H Woods, Huda Akil, Mary J. Clark, Alfred Mansour, Richard J. Miller, Gregory A. Kinney, Kyle W. Sloop, Kevin L. Duffin and Sudhakar Chintharlapalli. Their work appears in journals such as Nature Communications, Journal of Neuroscience and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact